Kraig Biocraft Laboratories, Inc Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2011 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Kraig Biocraft Laboratories, Inc quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2011 to Q4 2023.
  • Kraig Biocraft Laboratories, Inc Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $5.34M, a 9.32% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $5.34M +$456K +9.32% Dec 31, 2023 10-K 2024-04-01
Q4 2022 $4.89M +$544K +12.5% Dec 31, 2022 10-K 2024-04-01
Q4 2021 $4.34M +$528K +13.8% Dec 31, 2021 10-K 2023-03-29
Q4 2020 $3.82M +$436K +12.9% Dec 31, 2020 10-K 2022-03-16
Q4 2019 $3.38M +$469K +16.1% Dec 31, 2019 10-K 2021-03-12
Q4 2018 $2.91M -$1.42M -32.8% Dec 31, 2018 10-K 2020-03-27
Q4 2017 $4.33M +$499K +13% Dec 31, 2017 10-K 2019-03-29
Q4 2016 $3.84M +$511K +15.4% Dec 31, 2016 10-K 2018-03-23
Q4 2015 $3.32M +$495K +17.5% Dec 31, 2015 10-K 2017-03-22
Q4 2014 $2.83M +$5.25M Dec 31, 2014 10-K 2016-03-30
Q4 2013 -$2.42M -$386K -19% Dec 31, 2013 10-K 2015-03-31
Q4 2012 -$2.03M -$221K -12.2% Dec 31, 2012 10-K 2014-04-15
Q4 2011 -$1.81M Dec 31, 2011 10-K/A 2013-12-24
* An asterisk sign (*) next to the value indicates that the value is likely invalid.